AMBER MILLER: Open Payments
NPI 1013607035 · CROSSROADS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 12 payments from 6 companies in 2025. Trend: 2023 $80 · 2024 $490 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| ABBVIE INC. | 3 | $69 |
| Lilly USA, LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Wegovy, MOUNJARO, UBRELVY, Ozempic, QULIPTA, Kerendia, The Cologuard Plus Collection Kit, Veozah.
Industry payments across TX — which companies pay providers there.
